{"id":171050,"date":"2025-09-08T09:33:20","date_gmt":"2025-09-08T13:33:20","guid":{"rendered":"https:\/\/44.250.171.167\/?p=171050"},"modified":"2025-09-08T09:33:20","modified_gmt":"2025-09-08T13:33:20","slug":"cipla-q1-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/cipla-q1-fy26-earnings-results\/","title":{"rendered":"CIPLA Q1 FY26 Earnings Results"},"content":{"rendered":"<p><strong>Cipla Ltd<\/strong> is engaged in the business of pharmaceuticals, offering a wide range of medicines and healthcare products across multiple therapeutic areas. Presenting below its Q1 FY26 Earnings Results.<\/p>\n<h2><strong>Q1 FY26 Earnings Results:<\/strong><\/h2>\n<p><strong>Revenue:<\/strong> \u20b96,957 crore, up 3.93% year-on-year YoY from \u20b96,694 crore<br \/>\n<strong>Total Expenses:<\/strong> \u20b95,446 crore, up 3.87% YoY from \u20b95,243 crore<br \/>\n<strong>Consolidated Net Profit PAT:<\/strong> \u20b91,292 crore, up 9.96% YoY from \u20b91,175 crore<br \/>\n<strong>Earnings Per Share EPS:<\/strong> \u20b916.06, up 10.15% YoY from \u20b914.58<\/p>\n<h2><strong>Operational &amp; Strategic Update:<\/strong><\/h2>\n<p><strong>Revenue Growth:<\/strong> Revenue grew nearly 4%, driven by strong domestic sales and sustained performance in international markets<br \/>\n<strong>Cost Management:<\/strong> Expenses rose in line with revenue growth, reflecting controlled scaling of operations and investments in R&amp;D<br \/>\n<a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/f08b36a2-0581-4ba9-96cd-5af764b25f25.pdf\" target=\"_blank\" rel=\"noopener\">Profitability<\/a><strong>:<\/strong> Net profit increased by 10%, supported by improved operational efficiencies and better product mix<br \/>\n<strong>Business Focus:<\/strong> Continued emphasis on specialty products, respiratory therapies, and complex generics to drive growth<br \/>\n<strong>Strategic Initiatives:<\/strong> Focus on expanding market presence globally, augmenting pipeline with innovation and addressing emerging healthcare needs<\/p>\n<h2><strong>Corporate Developments in Q1 FY26:<\/strong><\/h2>\n<p>Cipla delivered steady revenue growth coupled with near double-digit profit increases. The company\u2019s balanced domestic and international footprint along with strong R&amp;D pipeline contributed to robust performance.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-171051\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/IP.png\" alt=\"CIPLA Q1 FY26 Earnings Results\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/IP.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/IP-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/IP-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/IP-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/IP-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n<h2><strong>Looking Ahead:<\/strong><\/h2>\n<p>Cipla aims to strengthen its position in key therapeutic areas, expand global reach, and invest in innovation to sustain growth. The company expects continued focus on specialty therapies and emerging markets to fuel long-term value creation in FY26 and beyond.<\/p>\n<p>Explore the company\u2019s past earnings and latest concall transcripts, <a href=\"https:\/\/44.250.171.167\/symbol\/cipla\/\">click here<\/a> to visit the AlphaStreet India News Channel<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cipla Ltd is engaged in the business of pharmaceuticals, offering a wide range of medicines and healthcare products across multiple therapeutic areas. Presenting below its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results: Revenue: \u20b96,957 crore, up 3.93% year-on-year YoY from \u20b96,694 crore Total Expenses: \u20b95,446 crore, up 3.87% YoY from \u20b95,243 crore Consolidated Net [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":171051,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-171050","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/IP.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":169408,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q1fy26-10-rise-in-profits\/","url_meta":{"origin":171050,"position":0},"title":"Cipla Ltd Q1 FY26 Earnings Results \u2013 4% Revenue Growth, 10% Rise in Net Profit","author":"Divyansh_Kasana","date":"July 28, 2025","format":false,"excerpt":"Cipla Limited is a leading global pharmaceutical company dedicated to ensuring access to affordable, high-quality medicines across diverse therapeutic segments, including respiratory, anti-retroviral, and chronic care. Headquartered in India and operating in over 80 countries, Cipla continues to advance innovation and patient-centric healthcare. Q1 FY26 Earnings Summary\u00a0(Apr\u2013Jun 2025) Revenue:\u00a0\u20b96,957 crore,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-13.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-13.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-13.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-13.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-13.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-13.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":171993,"url":"https:\/\/alphastreet.com\/india\/swiggy-q2-fy26-earnings-results\/","url_meta":{"origin":171050,"position":1},"title":"Swiggy Q2 FY26 Earnings Results","author":"Chirag Gupta","date":"October 31, 2025","format":false,"excerpt":"Founded in 2014, Swiggy Ltd is a new-age, consumer-first technology company offering users an easy-to-use convenience platform, accessible through a unified app. \u00a0 Q2 FY26 Earnings Results: Revenue from Operations: \u20b95,561 crore, up 54.4% YoY from \u20b93,601 crore, 12% QoQ growth. Consolidated Net Loss: \u20b91,092 crore (wider by 74% YoY\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Swiggy Q2 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Swiggy.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Swiggy.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Swiggy.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Swiggy.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Swiggy.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Swiggy.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":171959,"url":"https:\/\/alphastreet.com\/india\/railtel-q2-fy26-earnings-results\/","url_meta":{"origin":171050,"position":2},"title":"Railtel Q2 FY26 Earnings Results","author":"Chirag Gupta","date":"October 30, 2025","format":false,"excerpt":"RailTel was incorporated in 2000, with the objective of creating nationwide broadband and VPN services, telecom, and multimedia network, to modernize the train control operation and safety system of Indian Railways. It is a \"Navratna\" PSU of the Government of India. At present, RailTel's network passes through around 6,000 stations\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Railtel Corporation Q2 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Railtel-Corporation-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Railtel-Corporation-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Railtel-Corporation-Q2-FY26-Earnings-Results.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Railtel-Corporation-Q2-FY26-Earnings-Results.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Railtel-Corporation-Q2-FY26-Earnings-Results.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/Railtel-Corporation-Q2-FY26-Earnings-Results.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169906,"url":"https:\/\/alphastreet.com\/india\/sun-tv-network-q1-fy26-earnings-results\/","url_meta":{"origin":171050,"position":3},"title":"Sun TV Network Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"August 8, 2025","format":false,"excerpt":"Sun TV Network was established in 1985 as Sumangali Publications Private Limited and was later renamed as Sun TV Network Limited. Sun TV, the flagship channel of the company, was started in 1993. STNL is primarily involved in television broadcasting. Besides, it produces\/distributes movies under the banner Sun Pictures. Presenting\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Sun TV Network Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":171150,"url":"https:\/\/alphastreet.com\/india\/deepak-nitrite-q1-fy26-earnings-results\/","url_meta":{"origin":171050,"position":4},"title":"Deepak Nitrite Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"September 11, 2025","format":false,"excerpt":"Deepak Nitrite Ltd, incorporated in 1970, manufactures basic intermediates, fine & specialty chemicals, performance products, and phenolics. Presenting below its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results: Revenue: \u20b91,890 crore, down 12.78% year-on-year YoY from \u20b92,167 crore Total Expenses: \u20b91,759 crore, down 7.95% YoY from \u20b91,911 crore Consolidated Net\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"DEEPAKNTR Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169792,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q1-fy26-earnings-results-51-rise-in-profits\/","url_meta":{"origin":171050,"position":5},"title":"Lupin Ltd Q1 FY26 Earnings Results &#8211; 51% rise in Profits","author":"Chirag Gupta","date":"August 6, 2025","format":false,"excerpt":"Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Lupin Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/171050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=171050"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/171050\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/171051"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=171050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=171050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=171050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}